For the quarter ending 2026-03-31, EMMA has $18,696K in assets. $86,556K in debts. $1,072K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,072 | 2,127 | 293 | 886 |
| Accounts receivable, net | 2,048 | 2,804 | 2,619 | 2,071 |
| Inventories, net | 1,909 | 1,555 | 1,213 | 1,313 |
| Prepaid expenses and other current assets | 966 | 1,260 | 661 | 745 |
| Total current assets | 5,995 | 7,746 | 4,786 | 5,015 |
| Property and equipment, gross | 469 | 469 | 509 | - |
| Less accumulated depreciation | 371 | 356 | 381 | - |
| Property and equipment, net | 98 | 113 | 128 | 143 |
| Right of use assets | 736 | 766 | 799 | 830 |
| Investment in convertible bond | 11,664 | 12,604 | 14,876 | 17,188 |
| Other assets | 203 | 207 | 167 | 168 |
| Total assets | 18,696 | 21,436 | 20,756 | 23,344 |
| Accounts payable and accrued expenses | 24,487 | 22,615 | 21,759 | 19,373 |
| Operating lease liabilities, current portion | 349 | 348 | 348 | 348 |
| Conversion feature derivative, notes payable | 235 | 0 | - | - |
| Other current liabilities | 17,443 | 17,565 | 14,475 | 14,139 |
| Warrant derivative liabilities | 15 | 13 | 11 | 13 |
| Notes payable to related parties-Nonrelated Party | 7,529 | 8,019 | 7,640 | 8,267 |
| Notes payable to related parties-Related Party | 3,123 | 3,132 | 3,132 | 3,132 |
| Convertible notes payable, net of discount | 17,356 | 17,380 | 16,804 | 16,804 |
| Total current liabilities | 70,537 | 69,072 | 64,169 | 62,076 |
| Operating lease liabilities, less current portion | 1,324 | 1,409 | 1,498 | 1,584 |
| Other long-term liabilities | 12,418 | 12,292 | 12,313 | 13,128 |
| Notes payable to related parties, net of discount | 2,277 | 2,271 | 2,264 | 2,257 |
| Total liabilities | 86,556 | 85,044 | 80,244 | 79,045 |
| Common stock, par value 0.001 per share, 250,000,000 shares authorized, 70,188,263 shares issued and outstanding at march 31, 2026 2026 and december 31, 2025, respectively | 70 | 70 | 64 | 64 |
| Additional paid-in capital | 225,988 | 225,987 | 225,914 | 225,905 |
| Net loan receivable from ej holdings | 16,869 | 16,869 | 16,869 | 16,869 |
| Accumulated other comprehensive loss | -3,647 | -2,729 | -481 | 1,239 |
| Accumulated deficit | -273,402 | -270,067 | -268,116 | -266,040 |
| Total stockholders deficit | -67,860 | -63,608 | -59,488 | -55,701 |
| Total liabilities and stockholders' deficit | 18,696 | 21,436 | 20,756 | 23,344 |
Emmaus Life Sciences, Inc. (EMMA)
Emmaus Life Sciences, Inc. (EMMA)